One study has indicated that a lung cancer model based on PBMCs and xenograft cell line derived from the same donor was more accurate when evaluating PD-L1/PD-1 immunotherapy, compared to an HSC-based model of the same tumor [106]. Here, CD274 is linked to neoplasm.